Search
Utilizamos cookies para generar estadísticas que nos ayudan a mejorar la calidad de nuestro sitio web y su experiencia de usuario. Al hacer clic en «Aceptar todo», usted consiente el tratamiento de sus datos por parte de Acino y su transferencia a terceros. También puede personalizar su consentimiento para fines específicos de tratamiento de datos. Una vez que haya realizado su elección, haga clic en «Confirmar». Encontrará información detallada y podrá modificar sus preferencias en cualquier momento en nuestra Política de Privacidad .
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
ADQ plans to bolster its healthcare and pharma portfolio by acquiring Amoun Pharmaceutical Company
Amoun, part of Arcera, marks World Heart Day 2026.
Monday 12th October 2026
Promoting prevention, wellbeing, and community impact through awareness, education, and action. As part of Arcera’s global World Heart Day 2026...
The greatest investment the pharmaceutical industry can make is not in machines...
Thursday 24th September 2026
At AMOUN part of Arcera, we believe the future of pharmaceutical manufacturing starts with investing in the people who will...
Arcera Life Sciences reports progress on sustainability and responsible growth in 2025
Monday 14th September 2026
Arcera Life Sciences announces the publication of its 2025 Sustainability Report, highlighting progress in embedding sustainability across its newly integrated...
Amoun – Part of Arcera Signs MoU with Egypt Healthcare Authority to...
Tuesday 7th July 2026
In a step that underscores the growing importance of strategic collaboration in Egypt’s healthcare sector, Amoun – Part of Arcera has...
Arcera Life Sciences and Daewoong Expand Strategic Partnership to Bring Enavogliflozin to...
Monday 29th June 2026
Expansion builds on successful collaboration across Latin America and reinforces commitment to advancing innovative cardiometabolic therapies across international markets.
From Market Access to Innovation: How Arcera Is Expanding the Pathway for...
Friday 12th June 2026
Arcera provides medicines to patients across some of the world’s most dynamic and underserved healthcare markets. Through deep regulatory expertise, established commercial infrastructure, and a...
M42 and Arcera Partner to Advance Biopharma Localization and Next Generation Life...
Wednesday 3rd June 2026
Abu Dhabi, UAE – June 03, 2026: M42, a global health leader powered by technology, artificial intelligence, and genomics, and...
Acino, part of Arcera Recognized Among Ukraine’s Top Employers
Thursday 7th May 2026
Acino, part of Arcera in Ukraine has been named one of the Top 50 best employers in Ukraine and ranked...
Emirates Drug Establishment and Arcera Sign Agreement to Advance Pharmaceutical Manufacturing in...
Tuesday 5th May 2026
The partnership establishes a framework to strengthen local manufacturing, develop talent, and support long-term supply resilience. Abu Dhabi, United Arab...
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
Tuesday 28th April 2026
Abu Dhabi, United Arab Emirates and Shanghai, China, April 28, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences...